Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Joseph Meserve"'
Autor:
Joseph Meserve, Parambir Dulai
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Vedolizumab is known to be safe, well-tolerated, and effective. However, as personalization becomes an increasingly important aspect of IBD care and in lieu of guidelines to inform clinicians on positioning of biologics, there is a need to reliably p
Externí odkaz:
https://doaj.org/article/820643533435481489a44e16dcf7af75
Publikováno v:
Case Reports in Hepatology, Vol 2015 (2015)
Disseminated herpes simplex virus (HSV) is a rare cause of acute fulminant liver failure. We hereby present a case series of three patients with acute disseminated HSV with necrotizing hepatitis successfully treated with a week course of acyclovir. E
Externí odkaz:
https://doaj.org/article/97d4ab1421b5469a9d4c9419a408abea
Autor:
Yiran Zhang, Satimai Aniwan, A Weiss, Gursimran Kochhar, Sunanda V. Kane, Bo Shen, Matthew Bohm, Siddharth Singh, Eugenia Shmidt, Jean-Frederic Colombel, Corey A. Siegel, David Faleck, Edward V. Loftus, James P. Campbell, Mahmoud A. Rahal, Siri Kadire, Ronghui Xu, William J. Sandborn, David Hudesman, Arun Swaminath, Joseph Meserve, Robert Hirten, Vipul Jairath, Ryan C. Ungaro, Bruce E. Sands, Karen Lasch, Jenna L. Koliani-Pace, Brigid S. Boland, Parambir S. Dulai, Dana J. Lukin, Shreya Chablaney, Monika Fischer, Adam Winters, Gloria Tran, Shannon Chang, Sashidhar Varma
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Background & Aims We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice. Methods A multicenter, retrospective, observational cohort study (May 2014 to D
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 12
Clin Gastroenterol Hepatol
Clin Gastroenterol Hepatol
Background & aimsPatients with Crohn's disease (CD) treated with ustekinumab who experience inadequate response, or loss of response after standard induction and/or maintenance dosing may benefit from dose escalation. We conducted a systematic review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c6178ce5b3a9a18fa70971346b665ff
https://escholarship.org/uc/item/270528g4
https://escholarship.org/uc/item/270528g4
Autor:
Siddharth Singh, Joseph Meserve
Publikováno v:
Aliment Pharmacol Ther
Autor:
Bruce E. Sands, Robert Hirten, Keith Sultan, David Faleck, Jenna L. Koliani-Pace, Shannon Chang, Michelle Luo, Eugenia Shmidt, David Hudesman, William J. Sandborn, Youran Gao, Parambir S. Dulai, Bo Shen, Monika Fischer, Preeti Shashi, Dana J. Lukin, A Weiss, Sunanda V. Kane, Gursimran Kochhar, Jiao Yang, Arun Swaminath, Joseph Meserve, Satimai Aniwan, Edward V. Loftus, Siddharth Singh, Adam Winters, Matthew Bohm, Shreya Chablaney, Zhongwen Huang, Sashidhar Varma, Nitin Gupta, Brigid S. Boland, Karen Lasch, Jean-Frederic Colombel, Corey A. Siegel
Publikováno v:
Inflammatory Bowel Diseases
Background Vedolizumab effectiveness estimates immediately after Food and Drug Administration (FDA) approval for ulcerative colitis (UC) and Crohn’s disease (CD) are limited by use in refractory populations. We aimed to compare treatment patterns a
Publikováno v:
Gastroenterology. 162:S-309
Autor:
Joseph Meserve, Siddharth Singh
Publikováno v:
Gastroenterology
Endoscopic and histologic remission are important goals in the treatment of ulcerative colitis (UC). We investigated the correlation of the recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) and other established endo
Autor:
Joseph, Meserve, Antonio, Facciorusso, Ariela K, Holmer, Vito, Annese, William J, Sandborn, Siddharth, Singh
Publikováno v:
Aliment Pharmacol Ther
BACKGROUND: Immune checkpoint inhibitors may variably impact patients with pre-existing autoimmune diseases. AIMS: To evaluate the risks and outcomes of adverse events in patients with pre-existing inflammatory bowel diseases treated with immune chec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2ec0d02e1692134968cf10d6eeb5fc73
https://europepmc.org/articles/PMC8041067/
https://europepmc.org/articles/PMC8041067/
Autor:
Joseph Meserve, Nina Veeravalli, Abha G. Singh, Uma Mahadevan, Gretchen Bandoli, Christina D. Chambers, Jiyu Luo, Siddharth Singh, William J. Sandborn, Brigid S. Boland, Wenhong Zhu
Publikováno v:
Gastroenterology, vol 161, iss 1
Background & aimsWe conducted a retrospective cohort study to inform the safety of exposure to immunosuppressive and/or biologic agents around conception in expectant fathers with immune-mediated inflammatory diseases (IMIDs) on birth outcomes.Method